Archive

Confo Therapeutics forms Scientific Advisory Board as it accelerates development of proprietary drug discovery engine

28.02.2019​

Confo Therapeutics Announces Exclusive License Agreement with VIB for Novel Structure Determination Technology

03.01.2019​

Confo Therapeutics Appoints Chief Counsel Legal & Intellectual Property

06.12.2018​

Drug discovery collaboration with Roche

19.12.2017​

Drug discovery collaboration with Lundbeck

26.09.2017​

Confo Therapeutics is awarded EUR 2.6M

01.02.2017​

Confo Therapeutics to appoint Chairman

15.12.2016

CEO appointment

07.09.2016​

New CSO dr. Christel Menet

10.05.2016​

Financial closing

02.02.2016​